EMCC European Monitoring Centre on Change

Merck santé

Company/Organisation:
Merck santé

Geographic Location

Country: France
Region: Rhône-Alpes; Centre-Est
Location of affected unit(s): Lacassagne (Lyon)

Company

Sector: Manufacturing
Manufacture of pharmaceuticals, medicinal chemical and botanical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
Number Employed: 320
Group: Merck KGaA

Employment Effects

Announcement Date: 11-07-2003
Planned Job Reductions min: 320
Planned Job Reductions max: 320
Type of Restructuring: Internal restructuring
Employment Effect Start: 01-07-2003
Foreseen End Date: 01-06-2006
Direct Dismissals: 320

Additional Information

Merck Santé, subsidiary of Merck KGaA, announced a restructuring programme for its production and research and development (R&D) units in France. 320 jobs are affected at the Lacassagne (Lyon) unit. Half of the R&D department will be closed by the end of 2004 and half of the production department will be closed by mid-2006. Production will be transfered to the unit of Semoy (Loiret) and in Spain. The idea of the restructuring plan comes from two studies: 'Ipso' and 'Everest' from Boston Consulting Group and Accenture.